AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Pfizer Ltd. Regulatory Filings 2023

Jun 30, 2023

60507_rns_2023-06-30_09f025e6-001a-4b0c-8d6d-c87be40fea7d.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Pfizer Limited

==> picture [100 x 41] intentionally omitted <==

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

June 30, 2023

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, G Block Dalal Street, Fort Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Closure of Trading Window – Pfizer Limited

We would like to inform you that, for the purpose of declaration of unaudited financial results of the Company, for the quarter ended June 30, 2023, the trading window of the Company shall remain closed from Friday, June 30, 2023 (close of business) till 48 hours after the results are made public.

We request you to kindly take the above on record.

Thanking you,